Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients
Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients have?
Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients has 101 citations in the OpenAlex counts ScholarIQ stores.
When was Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients published?
Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients has 2015 year in the ScholarIQ index.
What is the open-access status of Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients?
Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients has gold oa status in the ScholarIQ index.
What is the DOI of Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients?
The DOI for Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients is on the source record.
What is the PMID of Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients?
The PMID for Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients is on the source record.
What is the OpenAlex record for Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients?
The OpenAlex for Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients is on the source record.